# Methylphenidate Hydrochloride Extended-Release

NDC: 0406-1830
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: SpecGx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20150929

FDA application: ANDA203583

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0406-1830"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0406-1830
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e11e093-4ff3-4bed-8fe9-3ee460b47303